KNEKane Biotech Inc.
0.0300CAD0.00%Mkt Cap: 4.48M $P/E:

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company d…

Key Statistics

Company
Market Cap4.48M $
Enterprise Value4.84M $
Revenue (TTM)42.66K $
Gross Profit-466 $
Net Income (TTM)-1.98M $
Revenue/Share0.0000 USD
Last Price0.0300 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-3.18
EV/Revenue113.51
P/S87.52
P/B-3.13
EPS (TTM)-0.01
EPS (Forward)
52W Range
0.015043% of range0.0500
52W High0.0500 CAD
52W Low0.0150 CAD
Profitability
Gross Margin-0.15%
Oper. Margin-1557.92%
EBITDA Margin0.00%
Profit Margin-636.00%
ROE364.51%
ROA-99.53%
Growth
Revenue Growth-89.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-2.37M $
CapEx (TTM)82.39K $
FCF Margin-3636.06%
FCF Yield-34.62%
Net Debt1.11M $
Net Debt/EBITDA-0.73
Balance Sheet
Debt/Equity-3.09
Current Ratio0.45
Quick Ratio0.16
Book Value/Sh-0.0080 CAD
Cash/Share0.0020 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateMar 13, 2017
Splits
Last Split1:5
Split DateMar 13, 2017
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.205.06M
Float105.21M
Insiders39.85%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.02%
Shares Short15.07K
Short (prev mo.)9.09K
Technical
SMA 500.0296 (+1.4%)
SMA 2000.0355 (-15.6%)
Beta0.31
S&P 52W Chg18.16%
Avg Vol (30d)177.21K
Avg Vol (10d)337.75K
Technical Indicators
RSI (14)53.8
MACD-0.0006
MACD Signal-0.0013
MACD Hist.+0.0007
BB Upper0.0326 CAD
BB Middle0.0262 CAD
BB Lower0.0199 CAD
BB Width48.66%
ATR (14)0.0038 CAD
Vol Ratio (20d)0.09x